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Glucagon Deficiency Causing Severe Neonatal Hypoglycemia in a Patient with Normal Insulin Secretion
Summary u n e v c n t f~~l prcgn;incy. lli\ Paki\tani parents ar-e clo\c relatives.
I n the presented patient glucagon secretion was not stimulated by hypoglycemia o r by infusion o f alanine. whereas insulin secretion responded normally t o changes i n blood glucose and alanine concentrations. T h e administration o f exogenous eluca---gon evoked an abnormally strong and prolonged hyperglycemic response. Gluconeogenesis was severely impaired, but there was n o accuniulation of the m a i n gluroneogenic precursor%. This was explained by the deficiency o f substrates f o r these precursors. and by shunting i n t o other pathways than gluconeogenesis.
The hypoglycemia was easy t o control neonatally, whereas the condition at 3 months o f age was critical. Treatment w i t h glucagon resulted i n a clinical improvement already observed the first day, whereas blood glucose normalized i n 2-3 days. A f t e r 1 week the improvement was striking. The prompt initial effect o f glucagon was ascribed t o increased ~i~o~y d s . the delayed glucose rise t o a n induction o f rluconeoeenesis. A t reexamination the rate o f gluconeogenesis had increased 3 times. Glucagon treatment caused significant increase i n pyruvate, free fatty acids, and insulin, whereas the alanine concentration fell. he suhcutaneous injection o f 0.1 m g zinc protamine glucagon per k g body weight resulted i n a plasma level o f about 900 p g l m l shortly after the injection, w i t h a subsequent exponential fall. T h e K value was 13.59/hr.
A brother and a sister probably died f r o m hypoglycemia. and the closely related Pakistani parents had a partly deficient glucagon secretion. A n autosomal recessive i n h i r i t e d disorder is suggested.
Speculation
Congenital glucagon deficiency would be expected t o cause hypoglycemia, but n o such case has so far been well documented. I n this paper a patient w i t h severe, persistent. neonatal hypoglycemia caused by an isolated glucagon deficiency is presented. This and similar cases may provide valuable information about the physiologic role o f glucagon.
(iluc;igon. the 20-amino acid hormone sccrctcd by the tu, cell\ of the islets of 1-angerhans in the p:incrca\, is a most powerful stirnularlt of hcpiitic glucose production. <iluc:igon ;intihodic\ injected into fa\ted rats cause a marked fill1 in hlood glucose concentration\ (I")), and bird.; m:tde glucagon deficient die within hours froni hyr)oglycenli;l ( 3 7 ) . In contr;~st, man has not yet heen proved to have an allsolute recluirement for gluci~gon. This paper pre\ent\ a paticnt with an isol;itcd glucagon deficiency. T r e a t~n c n t with e s o g c~~o u s gIuc;~gon w;i\ prohal3ly cssential for his surviv;il.
11-W I. a boy (Ilirth weight 3x1 0 g. length 5 1 c~n ) .
u;i\ horn o n Scptcml>cr-2 5 . 1075. 7 \\cck\ 1;iter than expected. iiftcr a n 0 4
At the grandparent level brother and sister m~irricd \ister itnd 1,rotIier. and son and clalightcr from these two couplca married c;lch other. liecoming parent\ of the patient to I>c clc\crihcd. The ~xircnts :tr~d ;I llrothcr horn in I073 arc living in good heiilth. \vhcrcaa a \i\tcr ~I I C I ;I brother. llorn in 1 c17 1 ;11ic1 1077. respectively, died in 1'akist:in at 4 . 5 month\ arid 4 months of age. rcspccti\.cl!. nith symptonl\ closely re\ernl>ling those of the piiticnt. The parents \\ere tolcl that the childreri had hy1loglycc-mia. T h e f;imily cilrnc to Nor\vay in 1')74.
. .
I lie piitient \\a\ ;idmitteel to the Ilcl~artrncnt o f I'ciliatrics.
I<ik\ho\pitalct. 0 \ 1 0 . o n hi\ third cia! of life I>cca~i\c of rcpc;ited attacks of con\,ulsivc movements in the upper cstrcrnities a n d cyano\is. l l c \\;I\ hypotonic, nith a weal; cry. 13loocl glucosc \va\ 15 mg/ill. and spirl;il fluicl gluco\c X mg/dl, tvhereas other routine laboratory findings were normal. including serurn clcctrolytcs and liver function tc\ts. Blood ketone I>odics were in the lo\ver norn~;il r:irigc.
Trc;itmcnt \ \ ; I \ s~icce\\fuIly \tarled with glucose intr;ivcnously.
and ~ifter : I few days normoglyccnii;~ \v:is maintaineel o n frccluent kcdings with extra gluco\e. At I month of age the condition \\as still good. Illit \inglc episode\ uith fasting qmptori1;itic hypoglyccrni;~ \\ere recordcd. From 1.5-7 months of age sc;ittcred attiicks of jittering \rere rcgi\tercd. and rne;iri hlood glucosc v;ilue\ \lo\\ ly decreased. despite intcrl\ive trc:it~ncnt with \,;trying tlier;~-p c~~t i c rcginlcr~s. /It 7.5 ri101itI1\ he got conv~ilsivc attack\. and a l?rc\iously normal liI<(i no\\ \uggcstciI epileptogcnic lesion\. l'he attacks incrc;~sccl in frequency in spite of anticonvulsant trcatrncnt. At 3 months of age the condition hecanic critical (1:ig. I ) . H c \ \ a \ hypotonic. scmicom:itous. ne;irly continuously Iiypoglyccnlic. ;inti an alarming n u n~h c r of sci/ure\ \vcrc rcgi\-tered. Houe\,cr. all efforts to treat the condition \\ere \\ithout succe\\. until glucagon \v;I\ introduced ;it 3 . 5 months of age ( Fig.   I ) .
Esccpt for the addition of glucagon, trcatriicnt was unch;inged. The fir-\t 5 day4 he rcccivcd short acting glucagon. 0 . I rng i.m. 6 times daily. thereafter zinc protarnine glucagon, 0 . 4 n~g s.c. twice daily. The convulsions cea\ed nhruptly (Fig. I ).
Alter I clay n l~~\ c l c tonus \\;I\ del'initcly incrc;iscd. preceding the increase in hlood glucosc. which gr;ldually rose to norni;il value4 in 3 days. During the first days of treatment the patient was irritable and \veeping. llut after I \seek the clinical iniprovcnlcnt was striking. There was good tonus. eye contact. and for the first time the patient was smiling.
After 3 \reek\ the glucagon injections were temporarily discontinued. T w o i1;iys Iiifcr hlood glucosc fell. and the nest few days he again got attacks of hypoplycenlia. 'l'hc glucagon tlicrapy \va\ rc\urncd and the paticnt \\;is rapidly re\torccl (Fig. 1 ) .
I n addition to glucagon the patient still needed estra glucose s~ipply. \vithout which Illood glucose tcnded to fall. At 4 . 5 niontlis of age IIF.<i h a s normal, and on discht~~.ge frorn ho\pital at the age of 5 . i months he \\;is in good health with only slightly retarded p\ychornotor-ic dcvclopmcnt. 7'hc tre;itnicnt was continued after dizchiirge, but con\idcring the scvcrc hypoglycemia .
VIDNES A N D 0YAS.E:TEH
A G E ( weeks1 Fig. I Amino ;~cids in plasma ant1 urinc \\ere determined \\it11 ;I conventional ion exchange procedure at the Dcpiirtnient of Clinical Chenii\try. Rikshospitalct. O\lo.
All investigations \\ere performed \\ ith the parent\' consent.
Plasma inirnunoreactive pi~ncreatic glucagon wax determined according to the method of tieding ( 2 5 ) . and Novo Research Institute kindly supplied us with the pancrc;ts gluc:igon specific antiserum K 964. glucagon for standards. and ['""IJglucagon. All samples \rere ass:ryed in triplicate. Reco\erics of glucagon addccl to blood ranged from 80-l 0Ori . and the intera\sq \ari;~tion of four determinations in a pliisma s:~niple containing 50 pg glucagoninil did not exceed the range of -t 7 pg/ml. T o clcterminc the concentration\ of nonspecific interfering plasma factor\ 5ome samples \\ere treated it\ dcscrit~crl hy Weirc.1 ril. ( 5 3 ) . The plucagon values presented li;~vc not hccn corrcctcrl for possible nonspecific interference.
Immunorcactivc insulin \\.a\ determined hy the method of Hales and Randlc ( 7 2 The results \rere compared \\ith the results of the same te\t in \ix patients (from 7 months to 3 . 5 years olrl) \\itti hypoglycemia. \\here di\o~-dcr\ of insulin and gluc;tgon secretion II;ILI Iiccn excluded. F;~sting Idood glucose values prior to the tc\t \\.ere \imilar in the patient and the control \~~h j c c t s (Fig. 2 ) . The \tandard gluc;~gon toleri~nce test \r.;~s performed hy injecting 0.02 mg gluci~gon/kg hody weight rapidly intr;ivcnously. and the intravenous glucose tolerance test hy rapid injection of 0 . 5 g glucosc/kg body \\eight. The tests \\ere performed in the niorning after fasting period\ varying hct\\ccn 5 and 12 hr. aceorcling to the tolerance of fasting.
-1'he it1 1.11~o method employed i\ h;~serl upon the appe:tr:ince of radioacti\'ity in gluco\c after intravenous injection of triice amount\ of llC'-l;~t>eled gluconeogenic s u h t r a t e s ( 5 pCi/kg hody \wight). Details of the method and its application ;Ire given elsc\\hcre (48-50). Briefly \umrnarizcd. The Ie\el of signific;~ncc \\:I\ c;~lcul;~tcd using Student'\ I-test for t\\o means o r the pail-cd /-test. :is judged appropriate. and a I' value of 0.05 was chosen a \ the \ignifici~ncc level. K \.slues for di\appe;ir;~~ice rate\ of injected cornpound\ \rere calculated after cornputi~ig the lea\t \tluares fit for arl exponential function of the form: C', = C',,e I". \\ Iicre C',, i\ the coricentr;~tion at ti~iic zero. and <', the concentratio11 at time .I'. The baseline values \\ere suhtractctl. The insulin to gluc;~gon riiolar ratio \\.a\ c;~lculated by the formula: [insulin (pU/ml)/glucagon (pg/ml)[ x 23.3 . Despite ~>rofounclly deprcsacd hlood glucose valuca, the I>a.;al plasnl;~ gluc;~gon conccrltr;~tioris were lo\\ ( T ;~h l c I ). Moreover. 75r ; of the lo\v glucagon concentration.; irpp:trcntly found coulel hc sho\\,n t o l3c caused 1>y norispecific p l a s m i~ interference. not rcl;rtcd t o pancrc;~tic gluc;~gon. T h e h;r\al in\ulin value\. on the o t h e r h a n d . were norrnitl.
T h e glucagon itnrl insulin secretion was further studied after atimirlation n i t h al;~ninc. T h e ;rl;rninc tolerance tc\t \\;I\ performed o n t~v o occasions: I ) at 2 . 5 month\ of age. l>cfore glucagon treatment \\a\ a t ;~r t c d , and 11) at 4 montha of age. aftcr discontinuation of glucagon treatment for 4 d ;~y \ . Aftcr the infuaion of ;tl;~ninc. pl;lsrna alanine conccntr-;~tio~i\ inCrc;l\cd to 30-40 time\ llaseline value\ aftcr 5 rnin. hoth in the patient ancl the control subject\. a n d there \\.a\ n o \ignil'icant differcncc in the \uh\cclucnt dccreaac. Ncvcrthclc\\. the glucagon \ccrction iri the paticnt dicl not increase. in contra\t to all of the control \uhject\. \r here the ri\c \\a\ rapid ancl highly 4ignificant (I' -0 . 0 0 5 ) (Fig. 2 ) . T h e in\ulin response. ho\\cvcr. \\as hri\k. \kith a rn;~sirnal incrcaac \\ithin the range of the control sul>jcct\. 13loocl glucose dccrca\ccl in the patient in contr;r\t to tlic control sutljccts.
Insulin \ccrction \\ ;IS also stircliecl irl response t o gluco\c. All intra\cnoua gluco\c tolerance tc\t \ \ ; I > performed \vlicn tlic 1>;1-ticnt was 7 ~~l o r i t l l \ oIcI. T h e irljcctcd glucose diaappearccl rapidly. the K v;~lue I3eing 7.5 ';/win. a high value at thi\ age ( 2 1 ;~n d 2 montha of age. In Figure 3 the t>lood gluco\c respon\c of the 13;rticnt is compared n i t h the rc\ponses of two hypoglycemic control a i r h i c c t~. 111 coritr-;tst to the r~orrii;~l I-canorisca of the control\, the IiIooc1 gluco\c incre;~\e in the patient \\a\ ahnormall\. atrong a n d \ustairicd. \\ith a long Iitsting ancl high pl:ttciru.
time the patient \ \ a s 2 nioriths 3 week\ old. i.~.. hcfore the gluc;tgon trciitrncnt \\as \t;~rtcel; the second time he hiid tlccn trcatecl with gluc;~gorl for 2 week\, ancl the stucly \\a\ performed 2 hr after 0 . 4 mg ~i n c prot;~riiinc glucayon had I3cen injected sut~cutaneou\Iy. T h e hasal hlood gluco\e \,aluc was 2 0 mg/dl 13cl'or-c the fir\t \tucly. and 100 rng/cll hefor-c the s c c o n~l . T h e h:~\al pl;l\ln;~ ;~l ;~n i n c conccntratioris \vcrc 2 13 ancl I 4 I prnol/ liter. arid the pyruvatc concentrations 2 3 a n d 03 prnol/litcr. r -c \~~c c t i \ c l y . ~l~l i c s c cor1ccritrirtion\ \ \ e r e r~iiriirii:~lly cliir~igccl 13) the injcction of t r ;~c c r . (1) ( ( 7 ) ( 2 ) ( 2 1 ( 3 ) T h e present report dcmoristratca cle:irly that glucagon dcficiency will c;iusc scvcrc hypoglycemi;~ in ;I patient wit11 normal insulin sccretion.
T h e diagnosis of gluc;tgon deficiency \\.:is not h;tsed mainly on low hi~sal glucagon concentrations. hut on the Iitck of response to hypoglycerni:~ and olaninc infusion. hoth known to he potent stimulators of glucitgon sccretion ( 1 6 . 30. 40. 5 4 ) . *]'his lack of response \vas detnonstrated on repcitted occasions. and contriistcd the highly significiint incre~ise in the control suhjccts (b'ig. 2 ) . Glucagon deficiency thus hits to he included in the list of kn(1u.n causes of neonatal persistent hypoplyccmi:~. and \ l~o~~l d ~ -he sought for in all c;iscs of hypoglycemia with ohscure etiology. Moreover. regarding the goocl results of treatment. glucagon secretion should he examined ;it a n early stage.
The disorder w;i\ congenital. and the f;trnily history and the findings in the parents suggest a n inherited disorder ~i t h ;in autosomal recessive mode of inheritance. We have no pancrc;i\ hiopxy of the patient anel do not knot\ the rnorphologic correlate to the disorder. hut the normal insulin secretion points to ii defect specifically involving the pancreatic t u , cells. leaving the p cells unaffected. The existence of cxtrapiincrc;itic t u , cells i\ disputctl in man (3. 3 8 ) in contrast to othcr specie\ s~i c h a \ the dog (34. 5 1 ) .
T h e tliologic role of glucagon is to ensure, in concert with insulin. :I steady supply of substrates under a wide range of physiologic condition\. T h e molar rittio of insuliri to g1uc:igon seems to he more important than the ah\olutc concentration of either ( 4 6 ) . In the [xiticnt clc.\cl.il~c.cI the mo\t \ignilic:int c1'fc.c.t 01' the unopposed insulin action was the scvcrc hypoglycemia, the cause of which might he deficiencies in three main nict:iholic proce\scs providing energy-yielding suhstr:~tes. namcly gluconeogenesis. glycogenolysis. and lipolysis ( 3 1 ) .
Gluconcogencsix normally starts after hirth (1 3 . 2 3 ) hy the normal postnatal increase of glucagon (17. 4 3 ) inducing the hepatic enzyme phosphocnolpyruv:itc carhosykinase. one of the key enzymes of gluconcogcnesis (7. 2 3 , 1 2 ) . I r i later lifc glucagon is an important stimul;itor ofgluconcogenesis in situation\ of glucose need ( 8 . 12. 13 ). The scvcrcly impaired gluconeogencsis in the presented patient was considerahly improved hy glucagon treatment. hut not quite norn~ulized (Fig. 4 ) . Ho\vcvcr, high blood glucose conccntr;itioris have hccn shown t o depress gluconeogenesis in both animals and in man ( I S . 35). iind hlood glucose in our patient rose 5-fold from the first to the second btudy. during the second study exceeding the mean hlood glucose v;ilues of the controls hy more than 407i ( 4 8 ) .
Glucagon is ;I potent hcpatoglycogenolytic agent ( 3 1 ). \\hcrc;is insulin stimulates the synthesis of glycogen. In o u r patient the ~thnorm;illy strong and prolonged hypcrglycerni;~ provoked hy the standard glucagon tolerance test s~rggested great deposits of glycogen in the liver, caused by the unopposed insulin action (Fig. 3 ) . The response further indicated csccs\ive sensitivity t o c.iogenou\ glucagon. as \vould I>c cspectctl in a patient with no gluc;tgon production of his o w n .
Cilucagon stimulates lipolysis and ketogcncsis ( 2 9 . 3 2 ) . therchy litwrating free fatty acids. glycerol, and ketone hodies. Kctonc hodies may largely substitute for glucose as fuel for the hrain ( 1 1 . 4 I ). and free fatty acids arc ;I main energy source for the liver. thus being a prerccluisite for the energy-recluiring process of gluconeogcnesis ( 6 ) . Furthermore. glycerol is r;ipidly converted to glucose in the liver ( I ) . In our patient the concentrations of free fatty acids and ketone bodies were in the lo\vcr normal range before glucagon treatment. and could not compensate for the low hlood glucose concentriitions. l'hc gluc;igon treatment c:iused a significant rise in free fatty acids (Tithle 1 ), thus providing the patient with additional energy-yielding suh\tr:ites.
Main precursors for gluconcogcnesis arc 1:ict:itc a n d the glucogenic amino acids, the majority of these precursors flo\\ing through pyruvate ( 1 3 , 14) . In our patient the conccntr;itions of lactate. pyruviite. and aliininc were low despite tlic severely impaired gluconcogcncsis. Although the othcr glucogcriic arnino acids tended to he high. alaninc is the ni;ijor precursor in thi\ contest ( 14) . I lou.evcr. in contrast with the othcr glucogenic amino acids. alaninc is chiefly synthesized de tro\'o from pvru- The hylx)glyc.crni;i in the, pr-cscntccl ~x i t i c~~t \ \ ; I \ initially c,:isy t c , control, n hcrcas the condition at 3 months of age \vas virtually resistant to conventional treatment. Varni:~ (11 (11. ( 4 7 ) demonstrated that dogs under 5 days of age were less sensitive to i n d i n action than u e r c adult dogs. The disiippearancc rate of glucose in man is low the first ncon:it:il days. incrc:ises to : I niasirnum Ilct\\ccn 4 and 12 ~n o n t h s of age. and then slowly decreases touards ~tdult levels ( 2 4 ) . A decreased glucose utiliziition during the first weeks of lifc might cspliiin the cliniciil course of our patient.
<iluc:igon trc;itnicnt resulted in a definite clinical improvement the first day of treatment. 2 days hefore hlood glucose had normiilized. This ohserviition may he explained hy the lipolytic effect of glucagon. rapidly increasing the conccntriitions of frcc fatty iicids and ketone hodies. uhereas nornialii.ation of hlood O u r p;~ticnt was treated with ~i n c protarnine glucagon. adrninistered subcutaneously in the amount of 0.1 mikg body weight twice d:rily. Plasma glucagon is normiilly lo\\, and sho\vs small fluctui~tions during the day ( 1 1 ) . The plasm;^ concentrations in our patient \ho\ved great v:tri;~tions. The mean gluciigon conccntrations. ho\vcvcr. might not he far from physiologic. as conccntrations in the portal circulation are higher than in peripheral blood ( 2 ) . and gluc;tgon is mainly acting on the liver. T o o high pl:~sm:~ glucagon concentr:ttions should he ;~voided. as they may cause hitrmful catabolic effects ( 3 0 ) .
tiypoglycernia in children has heen :~ttrihutcd to glucagon deficiency on several occ:tsions ( 1 X. 7 0 . 5 7 ) since the original description by McQuarric c.1 (11. ( 3 6 ) of presumed tu cell dcficiency in familial infantile hypoglyccn~i;~. These reports were hnsed upon histologic evidence of a reduced number of pancreatic ty cells. hut did not titkc into ilccount that only ;I small proportion o f the tu cells is comprised of tu, cells. being alone capable of secreting gluc;~gon. and the deficiencies \Yere not verified hy mc:~\urerncnt\ of panercirtic glucitgon. So far ;I dcf'iciency elf imm~~nore;tctive pancreatic gluc:~gon in hypoglycemia hi14 hcen reported only once in a young adult male ( 4 ) . tlo\v-ever, in this C ; I~C . there \\.;is deficient secretion of both insulin and gluc;~gon. This complic:tted the clinical picture. Furthermore. simil:tr dcficicncic\ are seen in unzpccifie islet cell destruction\ ( 1 0 ) .
A Pi~kistani hoy \\ith :I family history of infant deaths was admitted shortly after hirth heci~usc of hypoglycemic hcizurcs. After some initial in~provcment. his condition became critical with recurrence of the \cizurcs. Despite severe hypoglycemia. basal glucagon v:ilues were low. and did not increase after alanine infusion. Insulin sccretion \\as normal. (iluconeogencsi\ \+as sebcrely impaired. The hyperglycemic response to a standard gluc;tgon tolcr;~nce test was ahnormally \trong. .I'rc:ttrncnt with gl~lcitgc'n resulted in immediate cessation of the seizures. \vhc~-cas I > I i ) o~l glucose ~n c r c ;~z c c l 10 n o r m ; i l v ;~l u c h I n 3 c1;1y\.
Gluconcogenesis incrcirsed 3-fold. After 1 \\cck of glucagon treatment the clinical condition had \trikingly improved. and after 5 \veeks a previously ahnormal EEC; h i~d normitlizcd. Discontinuiition ofglucagon treatment resulted in ;I relapse. The clo\ely related parents also had lo\v glucagon value\, respontling weakly to stimulation ~i t h alaninc. A n autosomal rece\\ivc inherited disorder is sugge\ted. This is the first case dcscrihcd with normoinsulinemic glucagon deficicncy a\ the cause of pcrsistent neonatal hypoglycemia. 
